Sun Pharma Advanced Research Company Share Price Targets
Sun Pharma Advanced Research Company Limited | |||
 | Price: ₹129.43 (-4.3%) | ||
| 52 Week Low: ₹128.35 52 Week High: ₹472.80 | |||
| Market Capital: 7,257.93 Crore (Midcap) | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Sun Pharma Advanced Research Company Recent Performance
- 2: Sun Pharma Advanced Research Company Share Price Target - Tomorrow
- 2.1: Summary
- 3: Sun Pharma Advanced Research Company Share Price Target - Next Week
- 3.1: Weekly Target Summary
- 4: Sun Pharma Advanced Research Company Share Price Target - Next Month
- 4.1: Monthly Target Summary
Sun Pharma Advanced Research Company Recent Performance
Over the past 323 trading days, the value of Sun Pharma Advanced Research Company's stock has lost ₹106.47 (-45.13%). On 07 Nov 2023, one share was worth ₹235.90 and by 21 Feb 2025, the value dropped to ₹129.43. During this period it created a highest high of ₹472.80 and lowest low of ₹128.35.
Sun Pharma Advanced Research Company Share Price Target - Tomorrow
| Level | Value | Analysis |
|---|---|---|
| Tomorrow Target 3 | 188.05 (+45.29%) | Price Action: 09 Jan 2025 Low |
| Tomorrow Target 2 | 183.99 (+42.15%) | Price Action: 13 Jan 2025 High |
| Tomorrow Target 1 | 181.8 (+40.46%) | Price Action: 21 Jan 2025 High |
| Current Price | 129.43 | Sun Pharma Advanced Research Company's share price as of 21 Feb 2025 |
| Stop Loss 1 | 79.48 (-38.6%) | Price Action: Chart |
| Stop Loss 2 | 78.69 (-39.21%) | Price Action: Chart |
| Stop Loss 3 | 77.27 (-40.29%) | Price Action: Chart |
Summary
21 Feb 2025: Sun Pharma Advanced Research Company finished the day at ₹129.43, losing ₹-5.82 (-4.30%) in 1 day.
Our analysis for tomorrow predicts a potential movement of -40.30% to 45.29% with:
- Target prices: ₹181.8 to ₹188.05
- Support levels: ₹79.48 to ₹77.27
- Recent high: ₹136.30
- Recent low: ₹128.40
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Sun Pharma Advanced Research Company Share Price Target - Next Week
| Level | Value | Analysis |
|---|---|---|
| Next Week Target 3 | 136.61 (+5.54%) | Price Action: 20 Feb 2025 High |
| Next Week Target 2 | 135.2 (+4.45%) | Price Action: Nov 2019 Low |
| Next Week Target 1 | 133.57 (+3.19%) | Price Action: 17 Feb 2025 Low |
| Current Price | 129.43 | Sun Pharma Advanced Research Company's share price as of 21 Feb 2025 |
| Stop Loss 1 | 128.14 (-1%) | Price Action: Chart |
| Stop Loss 2 | 126.84 (-2%) | Price Action: Aug 2013 High |
| Stop Loss 3 | 124.7 (-3.66%) | Price Action: Oct 2013 Low |
Weekly Target Summary
For next week, our analysis suggests a potential movement range of -3.65% to 5.55% with:
- Upper targets: ₹133.57 to ₹136.61
- Support levels: ₹128.14 to ₹124.7
Sun Pharma Advanced Research Company Share Price Target - Next Month
| Level | Value | Analysis |
|---|---|---|
| Next Month Target 3 | 199.57 (+54.19%) | Price Action: 18 Nov 2024 High |
| Next Month Target 2 | 197.55 (+52.63%) | Price Action: 13 Nov 2024 Low |
| Next Month Target 1 | 195.13 (+50.76%) | Price Action: 08 Jan 2025 High |
| Current Price | 129.43 | Sun Pharma Advanced Research Company's share price as of 21 Feb 2025 |
| Stop Loss 1 | 110.05 (-14.98%) | Price Action: Apr 2013 Low |
| Stop Loss 2 | 108.95 (-15.83%) | Price Action: Chart |
| Stop Loss 3 | 106.99 (-17.34%) | Price Action: Chart |
Monthly Target Summary
Looking ahead to next month, technical analysis indicates:
- Potential price movement: -17.34% to 54.19% with:
- Target range: ₹195.13 to ₹199.57
- Support levels: ₹110.05 to ₹106.99
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
